Assessment of dietary exposure to deoxynivalenol and fumonisin in the population of infants and toddlers in Turkey.

This study aims to estimate dietary exposure to deoxynivalenol and fumonisins (FBs) of infants and toddlers in Turkey. A total of 75 processed cereal-based foods intended for infants and toddlers collected between July and October 2018, were analysed by high performance liquid chromatography (HPLC). DON was determined in 21.3% of samples with mean middle bound (MB) level of 28.4 µg/kg. Of the 16 quantifiable samples, only one showed values above 200 µg/kg. Fumonisin B1 (FB1) was detected at quantifiable levels only in three samples, while FB2 was not found in any sample. Estimated mean MB chronic dietary exposures to DON in infants and toddlers were 0.161 and 0.118 µg/kg b.w. per day, while 95th percentile (P95) MB exposures to DON were estimated at 0.564 and 0.414 µg/kg b.w. per day, respectively. Mean MB dietary exposures to FBs for infants and toddlers, respectively, were 0.093 and 0.068 µg/kg b.w. per day; P95 exposure estimates were 0.079 and 0.058 µg/kg b.w. per day. Both for DON and FBs, mean and P95 exposures of infants and toddlers did not exceeded the threshold level of 1 µg/kg b.w. per day and are therefore not of health concern.

Maternal fumonisin exposure as a risk factor for neural tube defects.

Fumonisins are mycotoxins produced by the fungus F. verticillioides, a common contaminant of maize (corn) worldwide. Maternal consumption of fumonisin B(1)-contaminated maize during early pregnancy has recently been associated with increased risk for neural tube defects (NTDs) in human populations that rely heavily on maize as a dietary staple. Experimental administration of purified fumonisin to mice early in gestation also results in an increased incidence of NTDs in exposed offspring. Fumonisin inhibits the enzyme ceramide synthase in de novo sphingolipid biosynthesis, resulting in an elevation of free sphingoid bases and depletion of downstream glycosphingolipids. Increased sphingoid base metabolites (i.e., sphinganine-1-phosphate) may perturb signaling cascades involved in embryonic morphogenesis by functioning as ligands for sphingosine-1-P (S1P) receptors, a family of G-protein-coupled receptors that regulate key biological processes such as cell survival/proliferation, differentiation and migration. Fumonisin-induced depletion of glycosphingolipids impairs expression and function of the GPI-anchored folate receptor (Folr1), which may also contribute to adverse pregnancy outcomes. NTDs appear to be multifactorial in origin, involving complex gene-nutrient-environment interactions. Vitamin supplements containing folic acid have been shown to reduce the occurrence of NTDs, and may help protect the developing fetus from environmental teratogens. Fumonisins appear to be an environmental risk factor for birth defects, although other aspects of maternal nutrition and genetics play interactive roles in determining pregnancy outcome. Minimizing exposures to mycotoxins through enhanced agricultural practices, identifying biomarkers of exposure, characterizing mechanisms of toxicity, and improving maternal nutrition are all important strategies for reducing the NTD burden in susceptible human populations.

Determination of fumonisins B1 and B2 in corn by liquid chromatography/mass spectrometry with immunoaffinity column cleanup: single-laboratory method validation.

A single-laboratory method validation was conducted to establish the effectiveness of an immunoaffinity column cleanup procedure followed by liquid chromatography/mass spectrometry (LCIMS) for the determination of fumonisins B1 and B2 (FBI + FB2) in corn. The test portion is extracted with acetonitrile-methanol-water (25 + 25 + 50). The extract is filtered, diluted with phosphate-buffered saline solution, and applied to an immunoaffinity column. FB1 + FB2 are removed with methanol and directly determined by reversed-phase LC with MS detection using selected-ion monitoring of 2 characteristic ions in each case. Test portions of blank corn samples were spiked with a mixture of FB1 + FB2 to give total levels of 200 and 500 ng/g, respectively. Recoveries of both FB1 and FB2 from spiked samples averaged 90.4-101%. Based on results for spiked raw corn (triplicates at 2 levels), the relative standard deviation for repeatability ranged from 2.8 to 7.1%. The accuracy of the method was demonstrated by analysis of Food Analysis Performance Assessment Scheme (FAPAS) test material. The method was also applied to a small survey of processed corn products such as corn chips, cornflakes, and popcorn.

Mycotoxin reduction in Bt corn: potential economic, health, and regulatory impacts.

Genetically modified (GM) Bt corn, through the pest protection that it confers, has lower levels of mycotoxins: toxic and carcinogenic chemicals produced as secondary metabolites of fungi that colonize crops. In some cases, the reduction of mycotoxins afforded by Bt corn is significant enough to have an economic impact, both in terms of domestic markets and international trade. In less developed countries where certain mycotoxins are significant contaminants of food, Bt corn adoption, by virtue of its mycotoxin reduction, may even improve human and animal health. This paper describes an integrated assessment model that analyzes the economic and health impacts of two mycotoxins in corn: fumonisin and aflatoxin. It was found that excessively strict standards of these two mycotoxins could result in global trade losses in the hundreds of millions US dollars annually, with the US, China, and Argentina suffering the greatest losses. The paper then discusses the evidence for Bt corn's lower levels of contamination of fumonisin and aflatoxin, and estimates economic impacts in the United States. A total benefit of Bt corn's reduction of fumonisin and aflatoxin in the US was estimated at 23 million dollars annually. Finally, the paper examines the potential policy impacts of Bt corn's mycotoxin reduction, on nations that are making a decision on whether to allow commercialization of this genetically modified crop.

Mycotoxin risk assessment for the purpose of setting international regulatory standards.

The 2003 Council for Agricultural Science and Technology Mycotoxin report states that one 21st century goal is the development of uniform regulations worldwide for foodborne mycotoxin contamination. This study informs that endeavor by a risk assessment and economic analysis of two important mycotoxins: fumonisins and aflatoxins. The goals are to identify the nations that would be most heavily impacted by tighter mycotoxin regulations, examine costs and benefits as a function of regulatory stringency, and address risk-risk tradeoffs between health benefits and economic losses from compliance with those regulations. Among industrial nations, the United States would experience the heaviest economic losses from more precautionary mycotoxin standards. Environmental conditions in the developing world, however, are more conducive to mycotoxin accumulation in crops. Contrary to concerns expressed among policymakers, the less developed countries that would likely experience the greatest loss from tighter mycotoxin standards are not sub-Saharan African nations, but China and Argentina. If a fumonisin standard of 0.5 mg/kg were adopted worldwide, total export losses from fumonisins in corn may exceed 300 million dollars annually: 3-fold higher than if the less stringent U.S. standard of 2 mg/kg were adopted. Likewise, export losses from aflatoxins in peanuts may exceed 450 million dollars under the current EU regulatory standard of 4 microg/kg: almost 5-fold higher than if the U.S. standard of 20 microg/kg were adopted. Stricter standards are unlikely to improve health significantly. In developing nations such as China where hepatitis B and C are prevalent, tighter aflatoxin standards may increase health risks until improved control methods for aflatoxins are found, as high-quality crops may be exported instead of being consumed domestically.